Systasy Bioscience GmbH

The technological progress made in biomedical research has radically changed the view to new treatment strategies. Modern genetic technologies can deliver disease-relevant targets but are insufficient to refill the empty drug discovery pipeline. We also offer innovative custom solutions with our technology to our strategic partners. A team of dedicated scientists from Systasy shall collaborate with your organisation to develop custom assays and provide tailored solutions. Systasy welcomes new partnership opportunities. Systasy is open to collaborations with Pharma and Biotech companies for innovation and development projects, where both parties share their strengths and together benefit.